UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000022863
Receipt No. R000026349
Official scientific title of the study A Study on the Effect of whey protein hydrolysate on Postprandial Blood Glucose
Date of disclosure of the study information 2016/06/24
Last modified on 2016/08/19 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Study on the Effect of whey protein hydrolysate on Postprandial Blood Glucose
Title of the study (Brief title) The Effect of whey protein hydrolysate on Postprandial Blood Glucose
Region
Japan

Condition
Condition Not applicable
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To explore inhibitory effect of whey protein hydrolysate on postprandial blood glucose level.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postprandial blood glucose level
Key secondary outcomes Blood insulin level
Blood C-peptide level
Blood total amino acid level
Blood BCAA level

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Single blind -investigator(s) and assessor(s) are blinded
Control Placebo
Stratification
Dynamic allocation NO
Institution consideration
Blocking NO
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Whey protein hydrolysate, single ingestion. Wash out 1 week. Placebo, single ingestion
Interventions/Control_2 Placebo, single ingestion. Wash out 1 week. Whey protein hydrolysate, single ingestion
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
60 years-old >
Gender Male
Key inclusion criteria 1) Subjects who can make self-judgment and are voluntarily giving written informed consent.
2) Males whose age 40 to 59 years old and meet the following conditions (1) and/or (2) at the day of screening test.
(1) Fasting blood glucose level is 100mg/dL to less than 126 mg/dL.
(2) HbA1c value is 5.8 to less than 6.5% (NGSP).
Key exclusion criteria 1) Seriously or progressive ill patients
2) Subjects who use pharmaceuticals regularly.
3) Subjects with food allergies
4) Subjects who excessive alcohol intake. (intake over 60g alcohol per day)
5) Subjects who have a smoking habit.
6) Subjects who donated 400 mL of blood within 12 weeks. Subjects who donated 200 mL of blood within 4 weeks. Subject who donated platelet blood within 2weeks.
7) Fasting blood glucose level over 126mg/dL, or HbA1c over 6.5% at the day of screening test.
8) Others who have been determined ineligible by principal investigator or sub-investigator.
Target sample size 10

Research contact person
Name of lead principal investigator Kentaro Kawanaka
Organization Fukuoka University
Division name Faculty of Sports and Health Science
Address 8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
TEL +81-92-871-6631
Email kawanaka@fukuoka-u.ac.jp

Public contact
Name of contact person Shihoko Nakashima
Organization Fukuoka University
Division name Faculty of Sports and Health Science
Address 8-19-1, Nanakuma, Jonan-ku, Fukuoka City, Fukuoka, 814-0180, Japan
TEL +81-92-871-6631
Homepage URL
Email shihoko@fukuoka-u.ac.jp

Sponsor
Institute Fukuoka University
Institute
Department

Funding Source
Organization Meiji Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 24 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 06 Month 21 Day
Anticipated trial start date
2016 Year 08 Month 14 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 06 Month 23 Day
Last modified on
2016 Year 08 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026349